Literature DB >> 27939502

Magnetic resonance imaging assessment of cardiac function in a swine model of hibernating myocardium 3 months following bypass surgery.

Laura L Hocum Stone1, Cory Swingen2, Christopher Holley2, Christin Wright2, Erin Chappuis2, Herbert B Ward2, Edward O McFalls3, Rosemary F Kelly2.   

Abstract

OBJECTIVE: Clinical studies demonstrate delayed recovery of hibernating myocardium (HM) following coronary artery bypass graft (CABG) surgery. Cardiac magnetic resonance (CMR) imaging is effective in identifying HM in clinical settings. Our animal model of HM shows partial but incomplete functional recovery 1 month following CABG using echocardiography. This study uses CMR imaging to determine completeness of recovery 3 months post-CABG.
METHODS: Swine (N = 12) underwent left anterior descending artery (LAD) 1.5-cm constrictor placement creating a territory of HM over 12 weeks. CMR at 12 weeks confirmed hibernation without infarction (N = 12). Off-pump left internal thoracic artery (LITA) to the LAD was performed in 9 animals. Three animals were killed as HM controls. CMR imaging was repeated in revascularized animals before death at 1 (n = 4) or 3 months (n = 5). CMR imaging was performed at baseline and with dobutamine infusion (5 μg/kg/min).
RESULTS: Twelve weeks after constrictor placement, CMR imaging confirmed viability in LAD region and LAD stenosis in all animals. In HM, wall thickening is reduced at baseline but with contractile reserve present during dobutamine infusion. Following revascularization, CMR imaging confirmed patent LITA graft (n = 9). Analysis of baseline regional function shows incomplete recovery of HM following CABG, with reduced contractile reserve at both 1 and 3 months post-CABG.
CONCLUSIONS: CMR imaging provides accurate spatial resolution of regional contractile function and confirms the presence of HM at 12 weeks following instrumentation of the LAD. Three months following CABG, partial recovery of HM with contractile reserve is present in the single LAD territory. Copyright Â
© 2016 The American Association for Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  cardiac MRI; hibernating myocardium; ischemia

Mesh:

Year:  2016        PMID: 27939502     DOI: 10.1016/j.jtcvs.2016.10.089

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery.

Authors:  Laura Hocum Stone; Christin Wright; Erin Chappuis; Mia Messer; Herbert B Ward; Edward O McFalls; Rosemary F Kelly
Journal:  J Vis Exp       Date:  2018-03-27       Impact factor: 1.355

2.  Fluoroscopy Guided Minimally Invasive Swine Model of Myocardial Infarction by Left Coronary Artery Occlusion for Regenerative Cardiology.

Authors:  Finosh G Thankam; Mohamed Radwan; Angelo Keklikian; Manreet Atwal; Taj Rai; Devendra K Agrawal
Journal:  Cardiol Cardiovasc Med       Date:  2022-08-24

3.  Early Elevation of Systemic Plasma Clusterin after Reperfused Acute Myocardial Infarction in a Preclinical Porcine Model of Ischemic Heart Disease.

Authors:  Denise Traxler; Andreas Spannbauer; Patrick Einzinger; Julia Mester-Tonczar; Dominika Lukovic; Johannes Winkler; Katrin Zlabinger; Alfred Gugerell; LJubica Mandic; Mariann Gyöngyösi; Noemi Pavo
Journal:  Int J Mol Sci       Date:  2020-06-28       Impact factor: 5.923

4.  A Novel MRI-Based Finite Element Modeling Method for Calculation of Myocardial Ischemia Effect in Patients With Functional Mitral Regurgitation.

Authors:  Yue Zhang; Vicky Y Wang; Ashley E Morgan; Jiwon Kim; Liang Ge; Julius M Guccione; Jonathan W Weinsaft; Mark B Ratcliffe
Journal:  Front Physiol       Date:  2020-03-13       Impact factor: 4.566

5.  CoQ10 enhances PGC1α and increases expression of mitochondrial antioxidant proteins in chronically ischemic swine myocardium.

Authors:  Laura Hocum Stone; Erin Chappuis; Christin Wright; Rosemary F Kelly; Edward O McFalls
Journal:  Nutr Metab (Lond)       Date:  2019-12-30       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.